Dena Grayson

Last updated

Dena Grayson
Dena Minning lo-res.jpg
Personal details
Born
Dena Minning

(1971-01-05) January 5, 1971 (age 53)
Melbourne, Florida, U.S.
Political party Democratic
Spouse Alan Grayson (m. 2016)
Education University of Florida (BSc)
Washington University (MSc, MD, PhD)
Website Campaign website

Dena Minning Grayson (born Dena Minning, January 5, 1971) is an American medical doctor and researcher. In 2016, she ran unsuccessfully for the Democratic nomination for the United States House of Representatives for Florida's 9th congressional district. [1]

Contents

Early life and education

Dena Minning Grayson was born on January 5, 1971, in Melbourne, Florida. Grayson graduated from Melbourne High School in 1988 [2] where she was a member of the varsity soccer team that captured the Florida High School State Championship in 1987. [3] She earned her Bachelor of Science degree [4] from the University of Florida in 1992. After graduating from college, Grayson enrolled in the Medical Scientist Training Program at Washington University School of Medicine, [5] where she earned an MD and a PhD in biochemistry and molecular cell biology. [4] [6] In 1999, The New York Times , [7] Science Daily and the Duke Chronicle [8] covered research on Ascaris hemoglobin [9] that Grayson had published in Nature , and stated, "The discovery may yield new therapies for diseases such as cancer, in which starving tumors of oxygen is a major therapeutic focus." [10] Grayson completed her internship in internal medicine at the University of California, San Francisco. [11] [12]

Career

Grayson has a medical degree. In the early 2000s, she shifted her focus to medical research as a way of treating multiple patients by finding cures. [13] She worked as a biotechnology consultant at MEDACorp from 2002-2003. [14] From 2003 to 2008, Grayson served as an Associate Director of Licensing and Director of Medical Sciences at Amgen, and worked on developing treatments for cancers, asthma, anemia, hypercholesterolemia, heart failure, and pain. While at Amgen, she was selected as a Henry Crown Fellow at the Aspen Institute in 2006. [15] Grayson then served as Vice President of Translational Sciences at 3-V Biosciences from 2008 to 2010, [14] where she oversaw the development of broad-spectrum antiviral drugs active against deadly viruses. She served as the Vice President of Translational Sciences for AlloCure from 2011 to 2014, where she led research on a mesenchymal stem cell therapy for acute kidney injury. In 2010, Grayson founded MedExpert Consulting, a biotechnology consulting company, where she helped research and develop BCX4430, a broad-spectrum antiviral drug that is active against Ebola, Marburg, Yellow Fever, Zika, and other deadly viral diseases. [16] [17] [18] [19] Grayson briefly lobbied for BioCryst Pharmaceuticals for 3 months in 2013 and for 1 month in 2014 to fund research of a treatment for Ebola and other deadly viruses. [18] [20] In 2014, she was co-author of an article published in Nature on the efficacy of BCX4430 against Marburg virus [16] and of a paper on the activity of BCX4430 against Yellow Fever. [17]

Politics

In 2016, she ran unsuccessfully for the Democratic nomination for the United States House of Representatives for Florida's 9th congressional district. [1] Since 2016, Grayson is a regular political commentator on Twitter, and asked onto media such as Fox News to speak on issues such as the Democrats proposal to reform elections. [21] Grayson attended the Michael Cohen hearing in February 2019. [22]

Personal

Since 2016, she has been married to former Congressman Alan Grayson. [23]

Related Research Articles

<i>The Hot Zone</i> 1995 nonfiction book by Richard Preston

The Hot Zone: A Terrifying True Story is a best-selling 1994 nonfiction thriller by Richard Preston about the origins and incidents involving viral hemorrhagic fevers, particularly ebolaviruses and marburgviruses. The basis of the book was Preston's 1992 New Yorker article "Crisis in the Hot Zone".

<span class="mw-page-title-main">Sylvia Mathews Burwell</span> American government official (born 1965)

Sylvia Mary Burwell is an American government and non-profit executive who was the 15th president of American University from June 1, 2017 to June 30, 2024. Burwell is the first woman to serve as the university's president. Burwell earlier served as the 22nd United States Secretary of Health and Human Services. President Barack Obama nominated Burwell on April 11, 2014. Burwell's nomination was confirmed by the Senate on June 5, 2014, by a vote of 78–17. She served as Secretary until the end of the Obama administration. Previously, she had been the Director of the White House Office of Management and Budget from 2013 to 2014.

<span class="mw-page-title-main">Pardis Sabeti</span> Iranian American scientist

Pardis Christine Sabeti is an American computational biologist, medical geneticist, and evolutionary geneticist. She is a professor in the Center for Systems Biology and Department of Organismic and Evolutionary Biology at Harvard University, professor of Immunology and Infectious Disease at the Harvard T.H. Chan School of Public Health, core institute member at the Broad Institute, and an investigator of the Howard Hughes Medical Institute.

<i>Zika virus</i> Species of flavivirus

Zika virus is a member of the virus family Flaviviridae. It is spread by daytime-active Aedes mosquitoes, such as A. aegypti and A. albopictus. Its name comes from the Ziika Forest of Uganda, where the virus was first isolated in 1947. Zika virus shares a genus with the dengue, yellow fever, Japanese encephalitis, and West Nile viruses. Since the 1950s, it has been known to occur within a narrow equatorial belt from Africa to Asia. From 2007 to 2016, the virus spread eastward, across the Pacific Ocean to the Americas, leading to the 2015–2016 Zika virus epidemic.

<span class="mw-page-title-main">Ebola</span> Viral hemorrhagic fever of humans and other primates caused by ebolaviruses

Ebola, also known as Ebola virus disease (EVD) and Ebola hemorrhagic fever (EHF), is a viral hemorrhagic fever in humans and other primates, caused by ebolaviruses. Symptoms typically start anywhere between two days and three weeks after infection. The first symptoms are usually fever, sore throat, muscle pain, and headaches. These are usually followed by vomiting, diarrhoea, rash and decreased liver and kidney function, at which point some people begin to bleed both internally and externally. It kills between 25% and 90% of those infected – about 50% on average. Death is often due to shock from fluid loss, and typically occurs between six and 16 days after the first symptoms appear. Early treatment of symptoms increases the survival rate considerably compared to late start. An Ebola vaccine was approved by the US FDA in December 2019.

Christopher Mores is an American (US) arbovirologist, trained in infectious disease epidemiology. He is a professor in the Department of Global Health at the Milken Institute School of Public Health, the program director for the Global Health Epidemiology and Disease Control MPH program, and is director of a high-containment research laboratory at the George Washington University in Washington, DC.

<span class="mw-page-title-main">Galidesivir</span> Antiviral drug

Galidesivir is an antiviral drug, an adenosine analog. It was developed by BioCryst Pharmaceuticals with funding from NIAID, originally intended as a treatment for hepatitis C, but subsequently developed as a potential treatment for deadly filovirus infections such as Ebola virus disease and Marburg virus disease, as well as Zika virus. Currently, galidesivir is under phase 1 human trial in Brazil for coronavirus.

<span class="mw-page-title-main">Zika virus outbreak timeline</span>

This article primarily covers the chronology of the 2015–16 Zika virus epidemic. Flag icons denote the first announcements of confirmed cases by the respective nation-states, their first deaths, and relevant sessions and announcements of the World Health Organization (WHO), and the U.S. Centers for Disease Control (CDC), as well as relevant virological, epidemiological, and entomological studies.

<span class="mw-page-title-main">Global Virus Network</span> International group of medical virologists

The Global Virus Network (GVN) is an international coalition of medical virologists whose goal is to help the international medical community by improving the detection and management of viral diseases. The network was founded in 2011 by Robert Gallo in collaboration with William Hall and Reinhard Kurth, and 24 countries were members of the network as of 2015. The GVN fosters research into viruses that cause human disease to promote the development of diagnostics, antiviral drugs and vaccines, and its mission includes strengthening scientific training and response mechanisms to viral outbreaks. The GVN has organized task forces for chikungunya, human T-lymphotropic virus, and Zika. The network is headquartered at the Institute of Human Virology at the University of Maryland School of Medicine, and Gallo serves as its scientific director.

<span class="mw-page-title-main">Julie Ledgerwood</span> American allergist and immunologist

Julie E. Ledgerwood is an American allergist and immunologist, who is the chief medical officer and chief of the Clinical Trials Program at the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health in Bethesda, Maryland. She is a Doctor of Osteopathic Medicine.

<span class="mw-page-title-main">MK-608</span> Chemical compound

MK-608 is an antiviral drug, an adenosine analog. It was originally developed by Merck & Co. as a treatment for hepatitis C, but despite promising results in animal studies, it was ultimately unsuccessful in clinical trials. Subsequently it has been widely used in antiviral research and has shown activity against a range of viruses, including Dengue fever, tick-borne encephalitis virus, poliovirus, and most recently Zika virus, in both in vitro and animal models. Since it has already failed in human clinical trials previously, it is unlikely MK-608 itself will be developed as an antiviral medication, but the continuing lack of treatment options for these emerging viral diseases means that much research continues using MK-608 and related antiviral drugs.

<span class="mw-page-title-main">NITD008</span> Chemical compound

NITD008 is an antiviral drug classified as an adenosine analog. It was developed as a potential treatment for flavivirus infections and shows broad spectrum antiviral activity against many related viruses such as dengue virus, West Nile virus, yellow fever virus, Powassan virus, hepatitis C virus, Kyasanur Forest disease virus, Omsk hemorrhagic fever virus, and Zika virus. However, NITD008 proved too toxic in pre-clinical animal testing to be suitable for human trials, but it continues to be used in research to find improved treatments for emerging viral diseases.

<span class="mw-page-title-main">John P. Woodall</span> American entomologist

John Payne Woodall (1935–2016), known as Jack Woodall, was an American-British entomologist and virologist who made significant contributions to the study of arboviruses in South America, the Caribbean and Africa. He did research on the causative agents of dengue fever, Crimean–Congo hemorrhagic fever, o'nyong'nyong fever, yellow fever, Zika fever, and others.

<span class="mw-page-title-main">Tara C. Smith</span> American epidemiologist and science communicator

Tara C. Smith is an American epidemiologist and science communicator. She is a professor at the Kent State University College of Public Health who studies zoonotic infections. Smith was the first to identify strains of methicillin-resistant Staphylococcus aureus associated with livestock in the United States.

Dr. Daniel R. Lucey is an American physician, researcher, clinical professor of medicine of infectious diseases at Geisel School of Medicine at Dartmouth, and a research associate in anthropology at the Smithsonian National Museum of Natural History, where he has co-organised an exhibition on eight viral outbreaks.

<span class="mw-page-title-main">Neil Ferguson (epidemiologist)</span> British epidemiologist and researcher

Neil Morris Ferguson is a British epidemiologist and professor of mathematical biology, who specialises in the patterns of spread of infectious disease in humans and animals. He is the director of the Jameel Institute, and of the MRC Centre for Global Infectious Disease Analysis, and head of the Department of Infectious Disease Epidemiology in the School of Public Health and Vice-Dean for Academic Development in the Faculty of Medicine, all at Imperial College London.

<span class="mw-page-title-main">Syra Madad</span> American pathogen preparedness expert

Syra Madad is an American pathogen preparedness expert and infectious disease epidemiologist. Madad is the Senior Director of the System-wide Special Pathogens Program at NYC Health + Hospitals where she is part of the executive leadership team which oversees New York City's response to the Coronavirus disease 2019 pandemic in the city's 11 public hospitals. She was featured in the Netflix documentary series Pandemic: How to Prevent an Outbreak and the Discovery Channel documentary The Vaccine: Conquering COVID.

Trudie Lang is a Professor of Global Health Research at the University of Oxford. She specialises in clinical trials research capacity building in low-resource setting, and helped to organise the trial for the drug brincidofovir during the 2014 Ebola virus outbreak.

Natalie E. Dean is an American biostatistician specializing in infectious disease epidemiology. Dean is currently an assistant professor of Biostatistics at the University of Florida. Her research involves epidemiological modeling of outbreaks, including Ebola, Zika and COVID-19.

References

  1. 1 2 "Grayson's wife loses primary for his seat". August 31, 2016.
  2. ↑ Old Friends. "Melbourne High School - Class of 1988". Old Friends. Retrieved July 29, 2015.
  3. ↑ Cheryl Gordon (February 27, 1987). "Pass Around The Award -- Melbourne Soccer Girls Share Honor". Orlando Sentinel. Retrieved July 29, 2015.
  4. 1 2 Aspen Institute. "Fellow Profile - Dena Minning". Aspen Institute. Archived from the original on March 5, 2016. Retrieved July 29, 2015.
  5. ↑ Linda Sage (October 24, 1996). "Pike studies bucket brigade of cell messengers". Washington University Record: 3. Retrieved July 29, 2015.
  6. ↑ "MSTP Alumni". Medical Scientist Training Program - Washington University. Retrieved July 31, 2015.
  7. ↑ Blakeslee, Sandra (October 5, 1999). "Thanks to a 'Horrible Worm,' New Ideas on Hemoglobin". The New York Times. Retrieved July 5, 2016.
  8. ↑ Ben Lopez (October 13, 1999). "Medical Center researchers discover new function of hemoglobin". The Chronicle. Retrieved July 27, 2015.
  9. ↑ Minning, Dena M; et al. (August 2, 1999). "Ascaris haemoglobin is a nitric oxide-activated 'deoxygenase'". Nature. 401 (6752): 497–502. Bibcode:1999Natur.401..497M. doi:10.1038/46822. PMID   10519555. S2CID   3486708.
  10. ↑ ScienceDaily (October 5, 1999). "Parasite Overturns Traditional Beliefs About The Evolution And Role Of Hemoglobin". ScienceDaily. Retrieved July 27, 2015.
  11. ↑ "Bloomberg Business Executive Profile - Dena M. Minning M.D., Ph.D." Bloomberg.com. Retrieved July 9, 2015.
  12. ↑ "As Dem Rep. Grayson runs for Senate seat, girlfriend reportedly runs for his". FOX News. Retrieved August 4, 2015.
  13. ↑ "Dena Grayson hosts free Health Clinic in East Orlando". The Orlando Political Observer. July 24, 2016. Archived from the original on July 27, 2016. Retrieved August 3, 2016.
  14. 1 2 Minning, Dena. "Dena Minning LinkedIn Profile". LinkedIn. Retrieved July 26, 2015.
  15. ↑ "Leadership Programs 2006 Great Xpectations Class". The Aspen Institute. Retrieved July 26, 2015.
  16. 1 2 Warren, T.K.; et al. (March 2, 2014). "Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430". Nature. 508 (7496): 402–405. Bibcode:2014Natur.508..402W. doi:10.1038/nature13027. PMC   7095208 . PMID   24590073.
  17. 1 2 Julander, Justin G.; Bantia, Shanta; Taubenheim, Brian R.; Minning, Dena M.; Kotian, Pravin; Morrey, John D.; Smee, Donald F.; Sheridan, William P.; Babu, Yarlagadda S. (2014). "BCX4430, a Novel Nucleoside Analog, Effectively Treats Yellow Fever in a Hamster Model". Antimicrobial Agents and Chemotherapy. 58 (11): 6607–6614. doi:10.1128/AAC.03368-14. PMC   4249364 . PMID   25155605.
  18. 1 2 Division, News (September 3, 2015). "HHS contracts to develop new Ebola drug". HHS.gov. Retrieved June 6, 2016.{{cite web}}: |first= has generic name (help)
  19. ↑ Pharmaceuticals, Biocryst. "Study Results From Zika Virus Infected Mice Treated With BCX4430 to be Presented at WHO Conference". GlobeNewswire News Room. Retrieved June 6, 2016.
  20. ↑ "Lobby Disclosure Search". disclosures.house.gov. Retrieved August 3, 2016.
  21. ↑ Ingraham, Laura. "Are Dems trying to distract and divide with election reform plan?". YouTube.com. Fox News. Retrieved March 22, 2019.
  22. ↑ Vankin, Jonathan. "Dena Grayson goes Viral". Inquisitr. Inquisitr. Retrieved March 22, 2019.
  23. ↑ FOX. "New Florida power couple: Mr. and Mrs. Grayson". WOFL. Archived from the original on June 6, 2016. Retrieved June 6, 2016.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.